About Us

Dr. Marzouk is currently the U.S. President of GenesisCare, a position she has held since August 2022. Previously, she has been the President of CareMore Health and Aspire Health, subsidiaries of Elevance; Managing Director, Health and Global Health Innovation, of AXA health insurance and health services business in Asia; and Cardinal Health’s Medical Segment Chief Medical Officer. Dr. Marzouk also served in the U.S. Army on active duty , where she practiced as a neurosurgeon and served in Iraq as a Major. She received an MBA from The Fuqua School of Business, Duke University, an MD from St. Louis University School of Medicine, and a BA from the Washington University in St. Louis. Dr. Marzouk also advises health technology companies and serves on the advisory boards in the healthcare industry.

Jan is a seasoned pharmaceutical industry executive with 15+ years of experience. Throughout his career, he has taken on roles with increasing responsibilities. Patient Centricity remains his top priority across the product development lifecycle from phase I clinical trials through
post-commercialization research. In particular, Jan has embraced the importance of the Voice of Patient by conducting research focused on Patient Reported Outcomes, Digiceutics, and Healthcare Data Informatics. With particular expertise in oncology, Jan has contributed to the emerging science in HEOR (Health Economics and Outcomes 

Research) to elevate the value of the pharmaceutical agents with the most important stakeholder in the oncology ecosystem, the patient. He currently leads an oncology team at Pfizer.

Juli Wessel, is an accomplished Chief Compliance & Privacy Officer leading successful efforts building compliance functions that meet both regulatory requirements and align with operational objectives.  She currently manages and oversees an enterprise wide compliance and privacy program for an integrated oncology, and multispecialty network, providing community based cancer can and other services in outpatient locations. She received her Masters in Health Services Administration (MHSA), a BA in Health Information Management from the University of Kansas Medical Center, and a BS from Central Missouri State University. 

Paul is a seasoned biotech/pharmaceutical industry executive with a passion for pursuing solutions to medical problems that 

improve patient's lives. Paul has spent more than 20 years in leadership roles in cross-functional drug development programs and in functional leadership at both large pharmaceutical 

companies such as Amgen and Eli Lilly as well as at smaller biotech companies such as Amylin and Locus Bioscience and has worked directly on projects leading to more than 6 drug 

approvals. Paul has a BSc from the University of British Columbia, Canada, an MBA from the University of California, Irvine and has a PhD from Vanderbilt Medical School in Cellular and Molecular Pathology. Paul is currently the Chief Development Officer at Locus Biosciences where he oversees all clinical and regulatory activities in series C.

Dr. KMB is a highly renowned board-certified radiation oncologist practicing in Southwest Florida. She received her undergraduate and medical degrees at Harvard University and completed her residency at the Harvard Radiation Oncology Program, a combined training program at Massachusetts General Hospital and Dana Farber Cancer 

Institute in Boston, MA. Dr. Mirabeau-Beale has extensive experience in treating all cancer types with an emphasis on breast, lung, prostate, 

and GI cancers. She utilizes an integrative care approach and develops her treatment plans using Intensity-Modulated Radiotherapy (IMRT), stereotactic radiosurgery techniques, stereotactic body radiotherapy techniques (SBRT), and other advanced techniques in radiation therapy. Dr. Mirabeau-Beale has been influential on a national level in providing input regarding breast cancer research. She serves as the co-chair for the US Breast Cancer Research Group for GenesisCare and is an invited speaker on breast cancer radiotherapy and cancer disparities at national meetings.

Rare combination of qualitative business development, quantitative, and operations skill set that you look for in someone to scale a Partnerships organization.